HEARTSCIENCES INC (HSCS) Stock Fundamental Analysis

NASDAQ:HSCS • US42254E3027

3 USD
-0.12 (-3.85%)
Last: Feb 13, 2026, 08:15 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to HSCS. HSCS was compared to 185 industry peers in the Health Care Equipment & Supplies industry. The financial health of HSCS is average, but there are quite some concerns on its profitability. HSCS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year HSCS has reported negative net income.
  • HSCS had a negative operating cash flow in the past year.
  • In the past 5 years HSCS always reported negative net income.
  • In the past 5 years HSCS always reported negative operating cash flow.
HSCS Yearly Net Income VS EBIT VS OCF VS FCFHSCS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -150.70%, HSCS is doing worse than 86.49% of the companies in the same industry.
  • HSCS's Return On Equity of -216.05% is on the low side compared to the rest of the industry. HSCS is outperformed by 73.51% of its industry peers.
Industry RankSector Rank
ROA -150.7%
ROE -216.05%
ROIC N/A
ROA(3y)-156.79%
ROA(5y)-165.73%
ROE(3y)-2372.45%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HSCS Yearly ROA, ROE, ROICHSCS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K -4K

1.3 Margins

  • Looking at the Gross Margin, with a value of 57.47%, HSCS is in line with its industry, outperforming 58.38% of the companies in the same industry.
  • In the last couple of years the Gross Margin of HSCS has grown nicely.
  • HSCS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.97%
GM growth 5Y15.56%
HSCS Yearly Profit, Operating, Gross MarginsHSCS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 -50K -100K -150K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • HSCS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • HSCS has more shares outstanding than it did 1 year ago.
  • HSCS has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for HSCS is higher compared to a year ago.
HSCS Yearly Shares OutstandingHSCS Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
HSCS Yearly Total Debt VS Total AssetsHSCS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M

2.2 Solvency

  • Based on the Altman-Z score of -19.73, we must say that HSCS is in the distress zone and has some risk of bankruptcy.
  • HSCS has a Altman-Z score of -19.73. This is amonst the worse of the industry: HSCS underperforms 87.57% of its industry peers.
  • HSCS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -19.73
ROIC/WACCN/A
WACC9.8%
HSCS Yearly LT Debt VS Equity VS FCFHSCS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 5M -5M

2.3 Liquidity

  • HSCS has a Current Ratio of 2.42. This indicates that HSCS is financially healthy and has no problem in meeting its short term obligations.
  • HSCS has a Current ratio (2.42) which is comparable to the rest of the industry.
  • HSCS has a Quick Ratio of 2.00. This indicates that HSCS is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.00, HSCS is in line with its industry, outperforming 54.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.42
Quick Ratio 2
HSCS Yearly Current Assets VS Current LiabilitesHSCS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • HSCS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 74.25%, which is quite impressive.
  • Looking at the last year, HSCS shows a very negative growth in Revenue. The Revenue has decreased by -76.34% in the last year.
  • The Revenue for HSCS have been decreasing by -41.50% on average. This is quite bad
EPS 1Y (TTM)74.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.56%
Revenue 1Y (TTM)-76.34%
Revenue growth 3Y-32.65%
Revenue growth 5Y-41.5%
Sales Q2Q%N/A

3.2 Future

  • HSCS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.44% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y59.35%
EPS Next 2Y28.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HSCS Yearly Revenue VS EstimatesHSCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 500K 1M
HSCS Yearly EPS VS EstimatesHSCS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 -20 -40 -60

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for HSCS. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HSCS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HSCS Price Earnings VS Forward Price EarningsHSCS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HSCS Per share dataHSCS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

  • HSCS's earnings are expected to grow with 28.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.44%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • HSCS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HEARTSCIENCES INC

NASDAQ:HSCS (2/13/2026, 8:15:14 PM)

3

-0.12 (-3.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)12-15
Earnings (Next)03-12
Inst Owners5.51%
Inst Owner Change17.79%
Ins Owners3.68%
Ins Owner Change75.21%
Market Cap9.54M
Revenue(TTM)8.70K
Net Income(TTM)-9.04M
Analysts82.5
Price Target10.81 (260.33%)
Short Float %1.05%
Short Ratio0.57
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.14%
Min EPS beat(2)18.47%
Max EPS beat(2)57.81%
EPS beat(4)3
Avg EPS beat(4)22.01%
Min EPS beat(4)-6.31%
Max EPS beat(4)57.81%
EPS beat(8)5
Avg EPS beat(8)-35.56%
EPS beat(12)7
Avg EPS beat(12)-27.5%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-21.48%
PT rev (3m)-21.48%
EPS NQ rev (1m)7.61%
EPS NQ rev (3m)59.13%
EPS NY rev (1m)41.17%
EPS NY rev (3m)41.17%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1096.55
P/FCF N/A
P/OCF N/A
P/B 2.28
P/tB 4.05
EV/EBITDA N/A
EPS(TTM)-6.88
EYN/A
EPS(NY)-3.28
Fwd EYN/A
FCF(TTM)-2.37
FCFYN/A
OCF(TTM)-2.36
OCFYN/A
SpS0
BVpS1.32
TBVpS0.74
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -150.7%
ROE -216.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.47%
FCFM N/A
ROA(3y)-156.79%
ROA(5y)-165.73%
ROE(3y)-2372.45%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.97%
GM growth 5Y15.56%
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 145.29%
Cap/Sales 460.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.42
Quick Ratio 2
Altman-Z -19.73
F-Score3
WACC9.8%
ROIC/WACCN/A
Cap/Depr(3y)199.15%
Cap/Depr(5y)121.34%
Cap/Sales(3y)570.65%
Cap/Sales(5y)345.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.56%
EPS Next Y59.35%
EPS Next 2Y28.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-76.34%
Revenue growth 3Y-32.65%
Revenue growth 5Y-41.5%
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-32.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year4.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-42.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-42.17%
OCF growth 3YN/A
OCF growth 5YN/A

HEARTSCIENCES INC / HSCS FAQ

What is the fundamental rating for HSCS stock?

ChartMill assigns a fundamental rating of 2 / 10 to HSCS.


Can you provide the valuation status for HEARTSCIENCES INC?

ChartMill assigns a valuation rating of 1 / 10 to HEARTSCIENCES INC (HSCS). This can be considered as Overvalued.


What is the profitability of HSCS stock?

HEARTSCIENCES INC (HSCS) has a profitability rating of 1 / 10.